Healthcare
PRODUCTS
-
Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.
-
Our model combines the depth and experience level of our people with effective tools and processes already in place that are designed to ensure your critical eTMF documents and content are secure, organized, readily accessible, and always in complete compliance with all relevant regulations.
-
Aragen with a team of experts converge to offer a diverse range of analytical capabilities. With our flexible service models, including Full-Time Equivalent (FTE) and Fee-for-Service (FFS), we tailor our support to your specific needs.
-
Fetal Bovine Serum (FBS) is a time tested, universal supplement used in cell culture. It provides many compounds that have been shown to satisfy specific metabolic requirements for the culture of cells, including hormones, growth factors, cell attachment factors, pH buffer, protease inhibitors, vitamins, minerals, lipids, and a variety of undefined components.
-
For successful regulatory outcomes, we provide quality medical writing services for clinical trial documents, safety updates, and marketing applications.
WHITE PAPERS AND CASE STUDIES
-
CRO Collaboration That Fuels Innovation For Specialty Biotechs
Delve into the advantages of specialty CRO collaborations and the strategic opportunities that lie ahead as the life sciences field continues to embrace innovation and collaboration.
-
Beyond Integration: Flexible Orchestration Of IRT And eCOA Solutions
Consider how integrated response technologies and electronic clinical outcomes assessments can improve configurability, study start-up, and flexible mid-study changes.
-
Oligonucleotide Synthesis: Scale-Up Made Simple
Scaling oligonucleotide synthesis isn't as straightforward as it seems. Explore key challenges, critical process parameters, and solutions for a smooth scale-up.
-
Robust Models For Supporting PV And Medical Information Activity
Learn how outsourcing local pharmacovigilance and medical information activities to an established safety organization can provide high-quality expertise and technology that meets demand.
-
Still Using Paper Diaries To Capture PRO Data? Read This.
Access real-world examples of how electronic patient-reported outcome measures (PROMs) optimize data quality and reliability and improve the statistical power of trial data.
-
PlantPAx Distributed Control System Reduces Downtime For Mallinckrodt
Learn how the nation's leading supplier in prescription pain medication completely upgraded their control system, resulting in greater diagnostic/troubleshooting information and reducing downtime.
-
Creating Sustainable Data In The Laboratory
In a laboratory setting, data is everywhere. Learn in-depth about data challenges, the importance of data lifecycle management in laboratories, and the need for data sustainability.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
How Syneos Health Tackles Protocol Complexities
Explore solutions employed by Syneos Health, a global contract research organization, to optimize Phase IIV clinical trials, particularly under a complex adaptive trial protocol.
-
Raise The Bar: Setting New Standards For The eCOA Industry
A paradigm shift may be necessary to increase the adoption of Electronic Clinical Outcome Assessments (eCOA) in clinical research. Explore six pivotal areas where eCOA standards can be improved.
-
Why Early Market Access Planning Is Crucial In CGT Commercial Strategy
Bringing cell and gene therapies (CGTs) to market and ensuring patient access is a complex process. Discover how developing a market access strategy and partnering with experts can help.
-
How To Recruit 236 Patients In An Osteoarthritis Study On Time During The Peak Of The Pandemic
A leading Eastern European contract research organization completed the recruitment of 236 subjects in a Phase 3 osteoarthritis study for Handok Inc. despite hurdles caused by the COVID-19 pandemic.
NEWS
-
Persistent Launches Population Health Management Solution Using Microsoft Azure OpenAI Service2/8/2024
Persistent Systems (BSE: PERSISTENT) and (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today launched an innovative Generative AI-powered Population Health Management (PHM) Solution in collaboration with Microsoft.
-
MadCap Software Acquires Xyleme To Expand Suite Of Intelligent Content Management Products1/11/2024
MadCap Software, Inc., the leader in multi-channel content authoring, management and publishing, backed by global investment firm Battery Ventures, today announced the acquisition of Xyleme, Inc., a leader in intelligent content management for the development, management, delivery, and syndication of vital proprietary learning and development (L&D) content across the enterprise.
-
CEA-Leti Device Integrates Light Sensing & Modulation, Bringing Key Scalability, Compactness And Optical-Alignment Advantages12/9/2024
CEA-Leti researchers have developed the first-reported device capable of sensing light and modulating it accordingly in a single device, using a liquid crystal cell and a CMOS image sensor.
-
U.S. Department Of Veterans Affairs Extends Oracle EHR Modernization Contract7/9/2024
Organizations reaffirm their commitment to deliver a modern commercial EHR solution to help improve care for our nation’s veterans.
-
Oracle Delivers New Electronic Health Record Innovations9/18/2024
Oracle Health continues to deliver electronic health record (EHR) innovations that help clinicians streamline routine tasks and deliver more efficient, informed patient care.